| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd93db7b24bee043241aeabd776f146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bab79a104e34c82839a1462b77bce7c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b1cdc8b269f472455e406981ed4884d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a38cf3fa46b43121a3aa71c650befb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_322c351b517327fe594aa7ef7505caf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b45d9d0220e67a2f18bb1496276eae62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ee0afb6d1bb6071f365f8235d0261f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28 |
| filingDate |
2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce946043ec60402a2f6ba17e3e97cd45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f3d1ae3921a7c206d5b4fd5e9351c57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f0069bdf68c629beee2ed0c36c23628
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e190759b913560dfd952885825e14575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21235765dc0db839d1bcfd2c4b48a726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5de173b038d66a2ebdc9dfed8e54a9cd |
| publicationDate |
2011-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011085981-A1 |
| titleOfInvention |
Arene chromium-carbonyl complexes, a method for the preparation of and us of as pharmaceutical |
| abstract |
The invention relates to novel chromium-carbonyl complexes and a method for the preparation of the latter as well as use of the inventive chromium-carbonyl complexes to inhibit NOD1 and/or NOD2 in the immune system of vertebrates. In a further aspect, the invention relates to the use of the inventive chromium-carbonyl complexes as pharmaceutical active ingredients in a pharmaceutical composition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11744874-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679141-B2 |
| priorityDate |
2010-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |